Patents by Inventor Marie Young

Marie Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6762291
    Abstract: A family of p53 tumor suppressor nucleic acid and protein isolated from several insect species is described. The p53 nucleic acid and protein can be used to genetically modify metazoan invertebrate organisms, such as insects and worms, or cultured cells, resulting in p53 expression or mis-expression. The genetically modified organisms or cells can be used in screening assays to identify candidate compounds that are potential pesticidal agents or therapeutics that interact with p53 protein. They can also be used in methods for studying p53 activity and identifying other genes that modulate the function of, or interact with, the p53 gene. Nucleic acid and protein sequences for Drosophila p33 and Rb tumor suppressors are also described.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: July 13, 2004
    Assignee: Exelixis, Inc.
    Inventors: Andrew Roy Buchman, Darren Mark Platt, Michael Martin Ollman, Lynn Marie Young, Madelyn Robin Demsky, Kevin Patrick Keegan, Lori Friedman, Casey Kopczynski, Jeffrey S. Larson, Stephanie A. Robertson
  • Publication number: 20030071075
    Abstract: An article containing an aqueous fabric care composition and a container for the composition to facilitate portability and encourage effective use of the composition away from the home. Also provided are kits including the acticles of the present invention in combination with one or more optional accessories including hangers, compression devices, weights, portable mats, air blowers, gloves, mitts, mini-irons and combinations thereof.
    Type: Application
    Filed: April 19, 2002
    Publication date: April 17, 2003
    Inventors: Gayle Marie Frankenbach, Toan Trinh, Ray Douglas Lotts, Yuko Nakamura, Anneke Margaret Kaminski, Sarah Marie Young, Alan Robert Dinniwell, Ted John Fitz, Elise Marie Boehm
  • Patent number: 5874563
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 23, 1999
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Kirk E. Fry, Lavonne Marie Young, Jeffrey M. Linnen, John Wages
  • Patent number: 5859230
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals infected with non-A, non-B, non-C, non-D, non-E hepatitis. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides. The antigens are useful in diagnostic methods for detecting the presence of N-(ABCDE) hepatitis agent infection in primates. The antigens are also useful in vaccine and antibody preparations. Methods are presented for the isolation of entire genomes corresponding to the N-(ABCDE) hepatitis agents.
    Type: Grant
    Filed: March 6, 1996
    Date of Patent: January 12, 1999
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Gregory R. Reyes, LaVonne Marie Young
  • Patent number: 5856134
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 5, 1999
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
  • Patent number: 5851124
    Abstract: A locking wire connecting device having a plurality of cylindrical housings of circular cross section, each of the housings containing plural rings of plural symmetric inwardly curving teeth, and an alloy pin embedded in a plastic retaining wall. A wire is inserted into each of the respective housings without removal of the wire insulation, until the pin fully contacts the respective wire and pushes the wire insulation firmly into the inwardly curving teeth, which will resist slippage or removal of the wire. This allows for quick, reliable and simple connecting of cut wires in an enclosed space.
    Type: Grant
    Filed: September 11, 1996
    Date of Patent: December 22, 1998
    Inventors: Bruce Lynn Young, Katherine Marie Young
  • Patent number: 5849532
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 15, 1998
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
  • Patent number: 5824507
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: October 20, 1998
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
  • Patent number: 5766840
    Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: June 16, 1998
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages